Clinical Trials Results - National Cancer Institute


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?

	NCI Highlights


	Virtual and Standard Colonoscopy Both Accurate Denosumab May Help Prevent Bone Loss Past Highlights



Results: 11 -20 of 94 Show results per page	View Search Criteria \| Help With Results

Last Modified: 7/1/1997


11.		Phase III Randomized Comparison of Systemic Infusion vs Intrahepatic Infusion of Floxuridine for Metastatic Liver Disease Secondary to Colorectal Adenocarcinoma (Summary Last Modified 07/97)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Completed				over 18				NCI				MSKCC-8284 NCI-T83-1331D, T83-1331

Last Modified: 4/1/1989


12.		Phase III Randomized Study of Continuous Intrahepatic Artery FUDR plus Conventional Symptomatic Treatment vs Conventional Symptomatic Treatment Only in Patients with Colorectal Hepatic Metastases (Summary Last Modified 04/89)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				75 and under								CRC-PHASE-III-88003 UKM-CRC-CRC-FUDR

Last Modified: 6/1/1997


13.		Phase III Comparison of Intrahepatic Artery FUDR and Systemic 5-FU vs No Chemotherapy Following Resection of 1-3 Hepatic Metastases in Patients with Colorectal Cancer (Summary Last Modified 06/97)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				18 and over				NCI				EST-9288 SWOG-8990, INT-0103, E9288

Last Modified: 11/1/1998


14.		Phase III Randomized Study of Adjuvant Hepatic Arterial FUDR plus Systemic 5-FU/CF vs Systemic 5-FU/CF Alone in Resected Hepatic Metastases from Colorectal Cancer (Summary Last Modified 11/98)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				18 and over				NCI				MSKCC-91137A6 NCI-H92-0023

Last Modified: 11/1/1994


15.		Phase III Randomized Study of FUDR Administered Over 14 Days as a Constant-Rate vs a Circadian-Timed Infusion in Patients with Metastatic Renal Cell Carcinoma (Summary Last Modified 11/94)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				any age				NCI				ALB-R01-CA31635 NCI-H92-0025

Last Modified: 7/17/2008 First Published: 12/16/2005


16.		Phase III Randomized Study of Adjuvant Therapy Comprising Oxaliplatin and Capecitabine With Versus Without Hepatic Arterial Infusion of Floxuridine in Patients Undergoing Surgical Resection and/or Ablation for Hepatic Metastases From Colorectal Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				18 and over				NCI				NSABP-C-09 NSABP-C-09, NCT00268463

Last Modified: 2/1/1995


17.		Phase I/II Study of Combined Intrahepatic Artery FUDR and Systemic 5-FU/CF for Hepatic Metastases from Colorectal Cancer (Summary Last Modified 02/95)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Closed				18 and over								UPCC-3292 NCI-V94-0530

Last Modified: 4/1/1999 First Published: 4/1/1998


18.		Phase I/II Study of Intraperitoneal Floxuridine with Cisplatin and/or Carboplatin for the Treatment of Epithelial Ovarian Cancer Confined to the Peritoneal Cavity (Summary Last Modified 04/1999)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Closed				18 and over				NCI				LAC-USC-5O942 LAC-USC-94C026-CC, NCI-G98-1392

Last Modified: 6/1/1999 First Published: 9/1/1998


19.		Phase I/II Study of Paclitaxel and Intraperitoneal Cisplatin with Escalating Doses of Intraperitoneal Floxuridine in Patients with Optimally Debulked Stage III Ovarian Epithelial Cancer (Summary Last Modified 06/1999)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Completed				18 and over				NCI				LAC-USC-5O982 NCI-G98-1461


20.		Phase I/II Continuous Intra-Arterial Infusion of FUDR Using an Implantable DAD for Cancer Metastatic to the Liver

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Closed				no age specified								UCCRC-3670 NCI-V83-0143

Select All on One Page


					< Previous 1 2 3 4 5 Next >

| | | | | | | |

A Service of the National Cancer Institute